<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="platform">4</item><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="id">3443</item><item key="factors"><item><item key="GSM460255"><item key="TREATMENT">Untreated</item></item></item><item><item key="GSM460255"><item key="TREATMENT">Untreated</item></item></item><item><item key="GSM460255"><item key="TREATMENT">Untreated</item></item></item><item><item key="GSM460258"><item key="TREATMENT">CDk-125</item></item></item><item><item key="GSM460258"><item key="TREATMENT">CDk-125</item></item></item><item><item key="GSM460258"><item key="TREATMENT">CDk-125</item></item></item><item><item key="GSM46026"><item key="TREATMENT">CDk-509</item></item></item><item><item key="GSM46026"><item key="TREATMENT">CDk-509</item></item></item><item><item key="GSM46026"><item key="TREATMENT">CDk-509</item></item></item></item><item key="ownerprofile_id">arrayexpress_sid</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-18486</item><item key="summary_wrapped">The effects of the CDK inhibitors PHA-848125 and PHA-690509 on the A2780 cell line were analysed by gene expression profiling. The A2780...</item><item key="pubmed_id">20679242</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">1</item><item key="sample_count">9</item><item key="tags"><item>cell</item><item>line</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">cdk-inhibitors-pha-848125-and-pha-690509-profiling</item><item key="geo_id_plat">E-GEOD-18486_A-AFFY-44</item><item key="name">CDK inhibitors PHA-848125 and PHA-690509 profiling on A2780</item><item key="created">Sep.15, 2014</item><item key="summary">The effects of the CDK inhibitors PHA-848125 and PHA-690509 on the A2780 cell line were analysed by gene expression profiling. The A2780 cell line was treated with PHA-848125 (CDk-125) or PHA-690509 (CDk-509) for 6 hours at a dose equal to 5 times the IC50. Untreated A2780 cells were used as a control. Three replicates per treatment.</item><item key="geo_gse_id">E-GEOD-18486</item><item key="species">human</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-18486/samples/</item></data></biogps>
